title: Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
abstract: 18F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of 18F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.
authors.affiliation: Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California 94305, USA. aquon@stanford.edu
authors.forename: Andrew
authors.initials: A
authors.lastname: Quon
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Fischbein
authors.forename: I Ross
authors.initials: IR
authors.lastname: McDougall
authors.forename: Quynh-Thu
authors.initials: QT
authors.lastname: Le
authors.forename: Billy W
authors.initials: BW
authors.lastname: Loo
authors.forename: Harlan
authors.initials: H
authors.lastname: Pinto
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Kaplan
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000628:therapy; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods* / Q000592:standards; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards; D019275:Radiopharmaceuticals; D013382:Subtraction Technique; D018511:Systems Integration; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed / Q000379:methods* / Q000592:standards; D014481:United States; D051598:Whole Body Imaging / Q000379:methods* / Q000592:standards
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18